位置:首页 > 蛋白库 > MO4L1_HUMAN
MO4L1_HUMAN
ID   MO4L1_HUMAN             Reviewed;         362 AA.
AC   Q9UBU8; B4DKN6; B7Z6R1; D3DW88; O95899; Q5QTS1; Q6NVX8; Q86YT7; Q9HBP6;
AC   Q9NSW5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 2.
DT   03-AUG-2022, entry version 220.
DE   RecName: Full=Mortality factor 4-like protein 1;
DE   AltName: Full=MORF-related gene 15 protein;
DE   AltName: Full=Protein MSL3-1;
DE   AltName: Full=Transcription factor-like protein MRG15;
GN   Name=MORF4L1; Synonyms=MRG15; ORFNames=FWP006, HSPC008, HSPC061, PP368;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9891081; DOI=10.1128/mcb.19.2.1479;
RA   Bertram M.J., Berube N.G., Hang-Swanson X., Ran Q., Leung J.K., Bryce S.,
RA   Spurgers K., Bick R.J., Baldini A., Ning Y., Clark L.J., Parkinson E.K.,
RA   Barrett J.C., Smith J.R., Pereira-Smith O.M.;
RT   "Identification of a gene that reverses the immortal phenotype of a subset
RT   of cells and is a member of a novel family of transcription factor-like
RT   genes.";
RL   Mol. Cell. Biol. 19:1479-1485(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   D'Esposito M., Cocchia M., Matarazzo M.R., Macmillan S., Mazzarella R.;
RT   "Two human homologs of the Drosophila dosage compensation gene msl-3 are
RT   located on the X chromosome.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RA   Guo S., Tong T., Zhang Z.;
RT   "Cloning and identification of cellular senescence associated genes from
RT   fibroblasts 2BS.";
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for 300
RT   previously undefined genes expressed in CD34+ hematopoietic stem/progenitor
RT   cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Aorta;
RA   Liu B., Zhao B., Wang X.Y., Xu Y.Y., Liu Y.Q., Song L., Ye J., Sheng H.,
RA   Gao Y., Zhang C.L., Wei Y.J., Zhang J., Song L., Jiang Y.X., Zhao Z.W.,
RA   Ding J.F., Liu L.S., Gao R.L., Wu Q.Y., Qiang B.Q., Yuan J.G., Liew C.C.,
RA   Zhao M.S., Hui R.T.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Colon, and Embryonic stem cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Embryonic stem cell, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 17-29; 42-51; 118-127; 156-173; 179-192; 228-240;
RP   244-261 AND 340-359, AND IDENTIFICATION IN NUA4 COMPLEX.
RX   PubMed=12963728; DOI=10.1074/jbc.c300389200;
RA   Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J.,
RA   Conaway R.C., Conaway J.W.;
RT   "Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-
RT   containing histone acetyltransferase complex.";
RL   J. Biol. Chem. 278:42733-42736(2003).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 120-362 (ISOFORMS 1/2).
RC   TISSUE=Brain;
RA   Mei G., Yu W., Gibbs R.A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   INTERACTION WITH MRFAP1 AND RB1.
RX   PubMed=11500496; DOI=10.1074/jbc.m103435200;
RA   Leung J.K., Berube N., Venable S., Ahmed S., Timchenko N.,
RA   Pereira-Smith O.M.;
RT   "MRG15 activates the B-myb promoter through formation of a nuclear complex
RT   with the retinoblastoma protein and the novel protein PAM14.";
RL   J. Biol. Chem. 276:39171-39178(2001).
RN   [15]
RP   IDENTIFICATION IN COMPLEX WITH RB1 AND MRFAP1, AND INTERACTION WITH RB1 AND
RP   KAT8.
RX   PubMed=12397079; DOI=10.1074/jbc.m203839200;
RA   Pardo P.S., Leung J.K., Lucchesi J.C., Pereira-Smith O.M.;
RT   "MRG15, a novel chromodomain protein, is present in two distinct
RT   multiprotein complexes involved in transcriptional activation.";
RL   J. Biol. Chem. 277:50860-50866(2002).
RN   [16]
RP   INTERACTION WITH PHF12; SIN3A AND TLE FAMILY MEMBERS.
RX   PubMed=12391155; DOI=10.1128/mcb.22.22.7868-7876.2002;
RA   Yochum G.S., Ayer D.E.;
RT   "Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional
RT   repression via associations with Pf1, mSin3A, and transducin-like enhancer
RT   of Split.";
RL   Mol. Cell. Biol. 22:7868-7876(2002).
RN   [17]
RP   REVIEW ON NUA4 COMPLEX.
RX   PubMed=15196461; DOI=10.1016/j.gde.2004.02.009;
RA   Doyon Y., Cote J.;
RT   "The highly conserved and multifunctional NuA4 HAT complex.";
RL   Curr. Opin. Genet. Dev. 14:147-154(2004).
RN   [18]
RP   FUNCTION, IDENTIFICATION IN NUA4 COMPLEX, AND IDENTIFICATION IN SIN3A
RP   COMPLEX.
RX   PubMed=14966270; DOI=10.1128/mcb.24.5.1884-1896.2004;
RA   Doyon Y., Selleck W., Lane W.S., Tan S., Cote J.;
RT   "Structural and functional conservation of the NuA4 histone
RT   acetyltransferase complex from yeast to humans.";
RL   Mol. Cell. Biol. 24:1884-1896(2004).
RN   [19]
RP   INTERACTION WITH MSL1 AND NUPR1.
RX   PubMed=19650074; DOI=10.1002/jcp.21889;
RA   Gironella M., Malicet C., Cano C., Sandi M.J., Hamidi T., Tauil R.M.,
RA   Baston M., Valaco P., Moreno S., Lopez F., Neira J.L., Dagorn J.C.,
RA   Iovanna J.L.;
RT   "p8/nupr1 regulates DNA-repair activity after double-strand gamma
RT   irradiation-induced DNA damage.";
RL   J. Cell. Physiol. 221:594-602(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-143, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH BRCA COMPLEX AND PALB2.
RX   PubMed=20332121; DOI=10.1242/jcs.060178;
RA   Hayakawa T., Zhang F., Hayakawa N., Ohtani Y., Shinmyozu K., Nakayama J.,
RA   Andreassen P.R.;
RT   "MRG15 binds directly to PALB2 and stimulates homology-directed repair of
RT   chromosomal breaks.";
RL   J. Cell Sci. 123:1124-1130(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 190-362, AND INTERACTION WITH
RP   MRFAP1.
RX   PubMed=17008723; DOI=10.1110/ps.062397806;
RA   Zhang P., Zhao J., Wang B., Du J., Lu Y., Chen J., Ding J.;
RT   "The MRG domain of human MRG15 uses a shallow hydrophobic pocket to
RT   interact with the N-terminal region of PAM14.";
RL   Protein Sci. 15:2423-2434(2006).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 190-362, AND MUTAGENESIS OF
RP   VAL-208; GLU-234; TYR-251 AND ASN-254.
RX   PubMed=16407074; DOI=10.1016/j.str.2005.08.019;
RA   Bowman B.R., Moure C.M., Kirtane B.M., Welschhans R.L., Tominaga K.,
RA   Pereira-Smith O.M., Quiocho F.A.;
RT   "Multipurpose MRG domain involved in cell senescence and proliferation
RT   exhibits structural homology to a DNA-interacting domain.";
RL   Structure 14:151-158(2006).
CC   -!- FUNCTION: Component of the NuA4 histone acetyltransferase (HAT) complex
CC       which is involved in transcriptional activation of select genes
CC       principally by acetylation of nucleosomal histones H4 and H2A. This
CC       modification may both alter nucleosome - DNA interactions and promote
CC       interaction of the modified histones with other proteins which
CC       positively regulate transcription. This complex may be required for the
CC       activation of transcriptional programs associated with oncogene and
CC       proto-oncogene mediated growth induction, tumor suppressor mediated
CC       growth arrest and replicative senescence, apoptosis, and DNA repair.
CC       The NuA4 complex ATPase and helicase activities seem to be, at least in
CC       part, contributed by the association of RUVBL1 and RUVBL2 with EP400.
CC       NuA4 may also play a direct role in DNA repair when directly recruited
CC       to sites of DNA damage. Also a component of the mSin3A complex which
CC       acts to repress transcription by deacetylation of nucleosomal histones.
CC       Required for homologous recombination repair (HRR) and resistance to
CC       mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and
CC       RAD51, but not BRCA1, to DNA-damage foci. {ECO:0000269|PubMed:14966270,
CC       ECO:0000269|PubMed:20332121}.
CC   -!- SUBUNIT: Component of the NuA4 histone acetyltransferase complex which
CC       contains the catalytic subunit KAT5/TIP60 and the subunits EP400,
CC       TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2,
CC       ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP,
CC       YEATS4/GAS41, VPS72/YL1 and MEAF6. The NuA4 complex interacts with MYC
CC       and the adenovirus E1A protein. MORF4L1 may also participate in the
CC       formation of NuA4 related complexes which lack the KAT5/TIP60 catalytic
CC       subunit, but which include the SWI/SNF related protein SRCAP. Component
CC       of the mSin3A histone deacetylase complex, which includes SIN3A, HDAC2,
CC       ARID4B, MORF4L1, RBBP4/RbAp48, and RBBP7/RbAp46. Interacts with RB1 and
CC       KAT8. May also interact with PHF12 and one or more as yet undefined
CC       members of the TLE (transducin-like enhancer of split) family of
CC       transcriptional repressors. Interacts with the N-terminus of MRFAP1.
CC       Found in a complex composed of MORF4L1, MRFAP1 and RB1. Interacts with
CC       the entire BRCA complex, which contains BRCA1, PALB2, BRCA2 and RAD51.
CC       Interacts with PALB2. Forms a complex with MSL1 and NUPR1.
CC       {ECO:0000269|PubMed:11500496, ECO:0000269|PubMed:12391155,
CC       ECO:0000269|PubMed:12397079, ECO:0000269|PubMed:12963728,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:17008723,
CC       ECO:0000269|PubMed:19650074, ECO:0000269|PubMed:20332121}.
CC   -!- INTERACTION:
CC       Q9UBU8; Q96B67: ARRDC3; NbExp=3; IntAct=EBI-399246, EBI-2875665;
CC       Q9UBU8; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-399246, EBI-10181188;
CC       Q9UBU8; Q13554: CAMK2B; NbExp=3; IntAct=EBI-399246, EBI-1058722;
CC       Q9UBU8; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-399246, EBI-10181988;
CC       Q9UBU8; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-399246, EBI-10175124;
CC       Q9UBU8; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-399246, EBI-10172181;
CC       Q9UBU8; P51116: FXR2; NbExp=3; IntAct=EBI-399246, EBI-740459;
CC       Q9UBU8; Q08379: GOLGA2; NbExp=3; IntAct=EBI-399246, EBI-618309;
CC       Q9UBU8; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-399246, EBI-2549423;
CC       Q9UBU8; Q6NT76-2: HMBOX1; NbExp=3; IntAct=EBI-399246, EBI-10212206;
CC       Q9UBU8; Q13422: IKZF1; NbExp=3; IntAct=EBI-399246, EBI-745305;
CC       Q9UBU8; Q96JM7: L3MBTL3; NbExp=3; IntAct=EBI-399246, EBI-2686809;
CC       Q9UBU8; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-399246, EBI-741037;
CC       Q9UBU8; P50221: MEOX1; NbExp=3; IntAct=EBI-399246, EBI-2864512;
CC       Q9UBU8; Q9Y605: MRFAP1; NbExp=7; IntAct=EBI-399246, EBI-995714;
CC       Q9UBU8; Q96HT8: MRFAP1L1; NbExp=9; IntAct=EBI-399246, EBI-748896;
CC       Q9UBU8; Q9NV56: MRGBP; NbExp=7; IntAct=EBI-399246, EBI-399076;
CC       Q9UBU8; Q15742: NAB2; NbExp=3; IntAct=EBI-399246, EBI-8641936;
CC       Q9UBU8; Q8IVL1: NAV2; NbExp=3; IntAct=EBI-399246, EBI-741200;
CC       Q9UBU8; Q96AQ6: PBXIP1; NbExp=3; IntAct=EBI-399246, EBI-740845;
CC       Q9UBU8; Q9H0H5: RACGAP1; NbExp=3; IntAct=EBI-399246, EBI-717233;
CC       Q9UBU8; Q04864: REL; NbExp=3; IntAct=EBI-399246, EBI-307352;
CC       Q9UBU8; Q12800: TFCP2; NbExp=3; IntAct=EBI-399246, EBI-717422;
CC       Q9UBU8; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-399246, EBI-741515;
CC       Q9UBU8; Q15025: TNIP1; NbExp=4; IntAct=EBI-399246, EBI-357849;
CC       Q9UBU8; P13805: TNNT1; NbExp=3; IntAct=EBI-399246, EBI-726527;
CC       Q9UBU8; Q8WV44: TRIM41; NbExp=3; IntAct=EBI-399246, EBI-725997;
CC       Q9UBU8; Q96DT7: ZBTB10; NbExp=3; IntAct=EBI-399246, EBI-10235384;
CC       Q9UBU8; Q96C00: ZBTB9; NbExp=4; IntAct=EBI-399246, EBI-395708;
CC       Q9UBU8; P0DTC9: N; Xeno; NbExp=4; IntAct=EBI-399246, EBI-25475856;
CC       Q9UBU8-2; Q99856: ARID3A; NbExp=3; IntAct=EBI-10288852, EBI-5458244;
CC       Q9UBU8-2; Q96B67: ARRDC3; NbExp=3; IntAct=EBI-10288852, EBI-2875665;
CC       Q9UBU8-2; Q5H9J7: BEX5; NbExp=3; IntAct=EBI-10288852, EBI-10243741;
CC       Q9UBU8-2; Q13554: CAMK2B; NbExp=3; IntAct=EBI-10288852, EBI-1058722;
CC       Q9UBU8-2; Q13554-3: CAMK2B; NbExp=3; IntAct=EBI-10288852, EBI-11523526;
CC       Q9UBU8-2; Q6UX04-2: CWC27; NbExp=3; IntAct=EBI-10288852, EBI-18939574;
CC       Q9UBU8-2; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-10288852, EBI-742054;
CC       Q9UBU8-2; Q9NPF5: DMAP1; NbExp=4; IntAct=EBI-10288852, EBI-399105;
CC       Q9UBU8-2; Q14919: DRAP1; NbExp=3; IntAct=EBI-10288852, EBI-712941;
CC       Q9UBU8-2; Q8NE31: FAM13C; NbExp=3; IntAct=EBI-10288852, EBI-751248;
CC       Q9UBU8-2; Q8IX29: FBXO16; NbExp=3; IntAct=EBI-10288852, EBI-12063229;
CC       Q9UBU8-2; P51116: FXR2; NbExp=3; IntAct=EBI-10288852, EBI-740459;
CC       Q9UBU8-2; Q96IK5: GMCL1; NbExp=3; IntAct=EBI-10288852, EBI-2548508;
CC       Q9UBU8-2; Q08379: GOLGA2; NbExp=3; IntAct=EBI-10288852, EBI-618309;
CC       Q9UBU8-2; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-10288852, EBI-11163335;
CC       Q9UBU8-2; O15499: GSC2; NbExp=3; IntAct=EBI-10288852, EBI-19954058;
CC       Q9UBU8-2; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-10288852, EBI-2549423;
CC       Q9UBU8-2; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-10288852, EBI-740641;
CC       Q9UBU8-2; P52292: KPNA2; NbExp=3; IntAct=EBI-10288852, EBI-349938;
CC       Q9UBU8-2; Q96JM7-2: L3MBTL3; NbExp=3; IntAct=EBI-10288852, EBI-11985629;
CC       Q9UBU8-2; P50458: LHX2; NbExp=3; IntAct=EBI-10288852, EBI-12179869;
CC       Q9UBU8-2; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-10288852, EBI-741037;
CC       Q9UBU8-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-10288852, EBI-16439278;
CC       Q9UBU8-2; O00566: MPHOSPH10; NbExp=3; IntAct=EBI-10288852, EBI-5235884;
CC       Q9UBU8-2; Q9Y605: MRFAP1; NbExp=15; IntAct=EBI-10288852, EBI-995714;
CC       Q9UBU8-2; Q96HT8: MRFAP1L1; NbExp=27; IntAct=EBI-10288852, EBI-748896;
CC       Q9UBU8-2; Q9NV56: MRGBP; NbExp=18; IntAct=EBI-10288852, EBI-399076;
CC       Q9UBU8-2; P52815: MRPL12; NbExp=3; IntAct=EBI-10288852, EBI-358272;
CC       Q9UBU8-2; Q15742: NAB2; NbExp=3; IntAct=EBI-10288852, EBI-8641936;
CC       Q9UBU8-2; Q8N987: NECAB1; NbExp=3; IntAct=EBI-10288852, EBI-11956853;
CC       Q9UBU8-2; Q969G9: NKD1; NbExp=3; IntAct=EBI-10288852, EBI-1538217;
CC       Q9UBU8-2; Q86YC2: PALB2; NbExp=3; IntAct=EBI-10288852, EBI-1222653;
CC       Q9UBU8-2; Q96AQ6: PBXIP1; NbExp=3; IntAct=EBI-10288852, EBI-740845;
CC       Q9UBU8-2; Q96QT6: PHF12; NbExp=6; IntAct=EBI-10288852, EBI-2803760;
CC       Q9UBU8-2; Q96QT6-2: PHF12; NbExp=3; IntAct=EBI-10288852, EBI-10293106;
CC       Q9UBU8-2; Q4G0R1: PIBF1; NbExp=3; IntAct=EBI-10288852, EBI-14066006;
CC       Q9UBU8-2; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-10288852, EBI-79165;
CC       Q9UBU8-2; Q9HB20: PLEKHA3; NbExp=3; IntAct=EBI-10288852, EBI-11079894;
CC       Q9UBU8-2; O95199: RCBTB2; NbExp=3; IntAct=EBI-10288852, EBI-742404;
CC       Q9UBU8-2; Q17R54: SYN3; NbExp=3; IntAct=EBI-10288852, EBI-12820047;
CC       Q9UBU8-2; Q96N21: TEPSIN; NbExp=3; IntAct=EBI-10288852, EBI-11139477;
CC       Q9UBU8-2; Q12800: TFCP2; NbExp=3; IntAct=EBI-10288852, EBI-717422;
CC       Q9UBU8-2; Q08117-2: TLE5; NbExp=3; IntAct=EBI-10288852, EBI-11741437;
CC       Q9UBU8-2; P45379-11: TNNT2; NbExp=3; IntAct=EBI-10288852, EBI-17559309;
CC       Q9UBU8-2; Q12933: TRAF2; NbExp=3; IntAct=EBI-10288852, EBI-355744;
CC       Q9UBU8-2; Q8WV44: TRIM41; NbExp=5; IntAct=EBI-10288852, EBI-725997;
CC       Q9UBU8-2; Q9NZI7: UBP1; NbExp=3; IntAct=EBI-10288852, EBI-2795133;
CC       Q9UBU8-2; O75436: VPS26A; NbExp=3; IntAct=EBI-10288852, EBI-1043891;
CC       Q9UBU8-2; Q9Y2W2: WBP11; NbExp=3; IntAct=EBI-10288852, EBI-714455;
CC       Q9UBU8-2; Q9HCK0: ZBTB26; NbExp=3; IntAct=EBI-10288852, EBI-3918996;
CC       Q9UBU8-2; O43298: ZBTB43; NbExp=3; IntAct=EBI-10288852, EBI-740718;
CC       Q9UBU8-2; Q8NAP8: ZBTB8B; NbExp=3; IntAct=EBI-10288852, EBI-17494306;
CC       Q9UBU8-2; Q96C00: ZBTB9; NbExp=3; IntAct=EBI-10288852, EBI-395708;
CC       Q9UBU8-2; Q8IWR0-2: ZC3H7A; NbExp=3; IntAct=EBI-10288852, EBI-12242934;
CC       Q9UBU8-2; Q8N554: ZNF276; NbExp=3; IntAct=EBI-10288852, EBI-750821;
CC       Q9UBU8-2; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-10288852, EBI-11962468;
CC       Q9UBU8-2; Q6P9G9: ZNF449; NbExp=3; IntAct=EBI-10288852, EBI-10215956;
CC       Q9UBU8-2; Q5SPL2: Phf12; Xeno; NbExp=2; IntAct=EBI-10288852, EBI-15963335;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UBU8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBU8-2; Sequence=VSP_012889;
CC       Name=3;
CC         IsoId=Q9UBU8-3; Sequence=VSP_046016;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG17253.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF100615; AAD29872.1; -; mRNA.
DR   EMBL; AF167173; AAF80854.1; -; mRNA.
DR   EMBL; AF218011; AAG17253.1; ALT_FRAME; mRNA.
DR   EMBL; AY148481; AAN65338.1; -; mRNA.
DR   EMBL; AF070664; AAD20970.1; -; mRNA.
DR   EMBL; AF161546; AAF29033.1; -; mRNA.
DR   EMBL; AF109188; AAQ13497.1; -; mRNA.
DR   EMBL; AK296650; BAG59248.1; -; mRNA.
DR   EMBL; AK300789; BAH13347.1; -; mRNA.
DR   EMBL; AL137697; CAB70879.2; -; mRNA.
DR   EMBL; AC011944; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99145.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99144.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99146.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99147.1; -; Genomic_DNA.
DR   EMBL; BC022845; AAH22845.1; -; mRNA.
DR   EMBL; BC002936; AAH02936.1; -; mRNA.
DR   EMBL; BC067826; AAH67826.1; -; mRNA.
DR   EMBL; CX165647; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF131847; AAD20058.1; -; mRNA.
DR   CCDS; CCDS10307.1; -. [Q9UBU8-1]
DR   CCDS; CCDS32304.1; -. [Q9UBU8-2]
DR   CCDS; CCDS58393.1; -. [Q9UBU8-3]
DR   PIR; T46285; T46285.
DR   RefSeq; NP_001252532.1; NM_001265603.1. [Q9UBU8-3]
DR   RefSeq; NP_001252533.1; NM_001265604.1. [Q9UBU8-3]
DR   RefSeq; NP_001252534.1; NM_001265605.1. [Q9UBU8-3]
DR   RefSeq; NP_006782.1; NM_006791.3. [Q9UBU8-2]
DR   RefSeq; NP_996670.1; NM_206839.2. [Q9UBU8-1]
DR   PDB; 2AQL; X-ray; 2.30 A; A/B=190-362.
DR   PDB; 2EFI; NMR; -; A=1-132.
DR   PDB; 2F5J; X-ray; 2.20 A; A/B=190-360.
DR   PDB; 2F5K; X-ray; 2.20 A; A/B/C/D/E/F=1-129.
DR   PDB; 2LKM; NMR; -; B=194-362.
DR   PDB; 2N1D; NMR; -; B=194-362.
DR   PDB; 6AGO; X-ray; 3.10 A; C/D=190-361.
DR   PDB; 6INE; X-ray; 2.60 A; B=190-362.
DR   PDBsum; 2AQL; -.
DR   PDBsum; 2EFI; -.
DR   PDBsum; 2F5J; -.
DR   PDBsum; 2F5K; -.
DR   PDBsum; 2LKM; -.
DR   PDBsum; 2N1D; -.
DR   PDBsum; 6AGO; -.
DR   PDBsum; 6INE; -.
DR   AlphaFoldDB; Q9UBU8; -.
DR   BMRB; Q9UBU8; -.
DR   SMR; Q9UBU8; -.
DR   BioGRID; 116134; 204.
DR   ComplexPortal; CPX-978; NuA4 histone acetyltransferase complex.
DR   CORUM; Q9UBU8; -.
DR   DIP; DIP-29017N; -.
DR   IntAct; Q9UBU8; 130.
DR   MINT; Q9UBU8; -.
DR   STRING; 9606.ENSP00000331310; -.
DR   ChEMBL; CHEMBL4630863; -.
DR   iPTMnet; Q9UBU8; -.
DR   MetOSite; Q9UBU8; -.
DR   PhosphoSitePlus; Q9UBU8; -.
DR   SwissPalm; Q9UBU8; -.
DR   BioMuta; MORF4L1; -.
DR   DMDM; 59803121; -.
DR   EPD; Q9UBU8; -.
DR   jPOST; Q9UBU8; -.
DR   MassIVE; Q9UBU8; -.
DR   MaxQB; Q9UBU8; -.
DR   PaxDb; Q9UBU8; -.
DR   PeptideAtlas; Q9UBU8; -.
DR   PRIDE; Q9UBU8; -.
DR   ProteomicsDB; 6799; -.
DR   ProteomicsDB; 84073; -. [Q9UBU8-1]
DR   ProteomicsDB; 84074; -. [Q9UBU8-2]
DR   Antibodypedia; 27748; 398 antibodies from 38 providers.
DR   DNASU; 10933; -.
DR   Ensembl; ENST00000331268.9; ENSP00000331310.5; ENSG00000185787.15. [Q9UBU8-1]
DR   Ensembl; ENST00000426013.7; ENSP00000408880.2; ENSG00000185787.15. [Q9UBU8-2]
DR   Ensembl; ENST00000558502.5; ENSP00000452808.1; ENSG00000185787.15. [Q9UBU8-3]
DR   Ensembl; ENST00000559345.5; ENSP00000452717.1; ENSG00000185787.15. [Q9UBU8-3]
DR   GeneID; 10933; -.
DR   KEGG; hsa:10933; -.
DR   MANE-Select; ENST00000426013.7; ENSP00000408880.2; NM_006791.4; NP_006782.1. [Q9UBU8-2]
DR   UCSC; uc002bel.5; human. [Q9UBU8-1]
DR   CTD; 10933; -.
DR   DisGeNET; 10933; -.
DR   GeneCards; MORF4L1; -.
DR   HGNC; HGNC:16989; MORF4L1.
DR   HPA; ENSG00000185787; Low tissue specificity.
DR   MIM; 607303; gene.
DR   neXtProt; NX_Q9UBU8; -.
DR   OpenTargets; ENSG00000185787; -.
DR   PharmGKB; PA134895182; -.
DR   VEuPathDB; HostDB:ENSG00000185787; -.
DR   eggNOG; KOG3001; Eukaryota.
DR   GeneTree; ENSGT00950000182965; -.
DR   InParanoid; Q9UBU8; -.
DR   OMA; GLQTYFD; -.
DR   OrthoDB; 1624495at2759; -.
DR   PhylomeDB; Q9UBU8; -.
DR   TreeFam; TF323400; -.
DR   PathwayCommons; Q9UBU8; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SignaLink; Q9UBU8; -.
DR   SIGNOR; Q9UBU8; -.
DR   BioGRID-ORCS; 10933; 34 hits in 1089 CRISPR screens.
DR   ChiTaRS; MORF4L1; human.
DR   EvolutionaryTrace; Q9UBU8; -.
DR   GeneWiki; MORF4L1; -.
DR   GenomeRNAi; 10933; -.
DR   Pharos; Q9UBU8; Tbio.
DR   PRO; PR:Q9UBU8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9UBU8; protein.
DR   Bgee; ENSG00000185787; Expressed in lateral nuclear group of thalamus and 209 other tissues.
DR   ExpressionAtlas; Q9UBU8; baseline and differential.
DR   Genevisible; Q9UBU8; HS.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IBA:GO_Central.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; IDA:ComplexPortal.
DR   GO; GO:0016580; C:Sin3 complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0048144; P:fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IBA:GO_Central.
DR   GO; GO:0016575; P:histone deacetylation; IDA:UniProtKB.
DR   GO; GO:0043968; P:histone H2A acetylation; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IDA:UniProtKB.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; IDA:ComplexPortal.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IC:ComplexPortal.
DR   GO; GO:0042981; P:regulation of apoptotic process; IC:ComplexPortal.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:ComplexPortal.
DR   GO; GO:2000779; P:regulation of double-strand break repair; IC:ComplexPortal.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.274.30; -; 1.
DR   IDEAL; IID00330; -.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR008676; MRG.
DR   InterPro; IPR038011; MRG15.
DR   InterPro; IPR038217; MRG_C_sf.
DR   InterPro; IPR026541; MRG_dom.
DR   InterPro; IPR025995; Tudor-knot.
DR   PANTHER; PTHR10880; PTHR10880; 1.
DR   PANTHER; PTHR10880:SF29; PTHR10880:SF29; 1.
DR   Pfam; PF05712; MRG; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   PIRSF; PIRSF038133; HAT_Nua4_EAF3/MRG15; 1.
DR   SUPFAM; SSF54160; SSF54160; 1.
DR   PROSITE; PS51640; MRG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Direct protein sequencing; DNA damage; DNA recombination; DNA repair;
KW   Growth regulation; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..362
FT                   /note="Mortality factor 4-like protein 1"
FT                   /id="PRO_0000088764"
FT   DOMAIN          12..51
FT                   /note="Tudor-knot"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          191..362
FT                   /note="MRG"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00972"
FT   REGION          26..62
FT                   /note="Interaction with KAT8"
FT                   /evidence="ECO:0000269|PubMed:12397079"
FT   REGION          113..182
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          133..266
FT                   /note="Sufficient for interaction with SIN3A"
FT                   /evidence="ECO:0000269|PubMed:12391155"
FT   REGION          164..230
FT                   /note="Interaction with RB1-1"
FT   REGION          188..342
FT                   /note="Sufficient for interaction with PHF12"
FT                   /evidence="ECO:0000269|PubMed:12391155"
FT   REGION          323..344
FT                   /note="Interaction with RB1-2"
FT   MOTIF           135..146
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        156..170
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         143
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1..127
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046016"
FT   VAR_SEQ         52..91
FT                   /note="KSAVRPRRSEKSLKTHEDIVALFPVPEGAPSVHHPLLTSS -> N (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11042152,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:9891081, ECO:0000303|Ref.2,
FT                   ECO:0000303|Ref.6"
FT                   /id="VSP_012889"
FT   MUTAGEN         208
FT                   /note="V->E: Abolishes binding to MRFAP1."
FT                   /evidence="ECO:0000269|PubMed:16407074"
FT   MUTAGEN         234
FT                   /note="E->R: No effect on MRFAP1 binding."
FT                   /evidence="ECO:0000269|PubMed:16407074"
FT   MUTAGEN         251
FT                   /note="Y->A: No effect on MRFAP1 binding."
FT                   /evidence="ECO:0000269|PubMed:16407074"
FT   MUTAGEN         254
FT                   /note="N->C: Reduces binding to MRFAP1."
FT                   /evidence="ECO:0000269|PubMed:16407074"
FT   CONFLICT        224
FT                   /note="P -> R (in Ref. 11; AAH67826)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261
FT                   /note="K -> KK (in Ref. 6; CAB70879)"
FT                   /evidence="ECO:0000305"
FT   STRAND          16..36
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   STRAND          39..46
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:2EFI"
FT   STRAND          94..97
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   HELIX           98..100
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   HELIX           106..125
FT                   /evidence="ECO:0007829|PDB:2F5K"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           204..215
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   STRAND          219..221
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   STRAND          226..228
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           229..241
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   STRAND          242..245
FT                   /evidence="ECO:0007829|PDB:6AGO"
FT   STRAND          247..249
FT                   /evidence="ECO:0007829|PDB:6AGO"
FT   HELIX           252..271
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           275..277
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           278..287
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           293..296
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           299..313
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           320..339
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           341..344
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           347..349
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   STRAND          350..352
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   HELIX           355..358
FT                   /evidence="ECO:0007829|PDB:2F5J"
FT   TURN            359..361
FT                   /evidence="ECO:0007829|PDB:2LKM"
SQ   SEQUENCE   362 AA;  41474 MW;  96B76BCA801F1187 CRC64;
     MAPKQDPKPK FQEGERVLCF HGPLLYEAKC VKVAIKDKQV KYFIHYSGWN KKSAVRPRRS
     EKSLKTHEDI VALFPVPEGA PSVHHPLLTS SWDEWVPESR VLKYVDTNLQ KQRELQKANQ
     EQYAEGKMRG AAPGKKTSGL QQKNVEVKTK KNKQKTPGNG DGGSTSETPQ PPRKKRARVD
     PTVENEETFM NRVEVKVKIP EELKPWLVDD WDLITRQKQL FYLPAKKNVD SILEDYANYK
     KSRGNTDNKE YAVNEVVAGI KEYFNVMLGT QLLYKFERPQ YAEILADHPD APMSQVYGAP
     HLLRLFVRIG AMLAYTPLDE KSLALLLNYL HDFLKYLAKN SATLFSASDY EVAPPEYHRK
     AV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024